Suchergebnisse - "Izadi, Sepideh"

PubPharm (31)

1

Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

enthalten in: Cell communication and signaling : CCS | 2023

von Khodakarami, A. | Kashani, M. | Nazer, A. | +13

2

Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

enthalten in: Cell communication and signaling | 2023

von Khodakarami, A. | Kashani, M. | Nazer, A. | +13

3

Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

enthalten in: Cell communication and signaling | 2023

von Khodakarami, A. | Kashani, M. | Nazer, A. | +13

4

Density-Dependence of Surface Transport in Tellurium-Enriched Nanograined Bulk Bi2 Te3

enthalten in: Small (Weinheim an der Bergstrasse, Germany) | 2023

von Izadi, S. | Bhattacharya, A. | Salloum, S. | +11

5

Retraction Note : Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression

enthalten in: Pharmaceutical research | 2022

von Izadi, S. | Moslehi, A. | Kheiry, H. | +14

RetractionOf: Pharm Res. 2020 Sep 17;37(10):196. - PMID 32944844

6

Extended-release of doxorubicin through green surface modification of gold nanoparticles : in vitro and in ovo assessment

enthalten in: BMC chemistry | 2022

von Asariha, M. | Kiaie, S. | Izadi, S. | +3

7

Extended-release of doxorubicin through green surface modification of gold nanoparticles: in vitro and in ovo assessment

enthalten in: BMC chemistry | 2022

von Asariha, M. | Kiaie, S. | Izadi, S. | +3

8

Extended-release of doxorubicin through green surface modification of gold nanoparticles: in vitro and in ovo assessment

enthalten in: Chemistry central journal | 2022

von Asariha, M. | Kiaie, S. | Izadi, S. | +3

9

Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses

enthalten in: Life sciences | 2022

von Adibfar, S. | Masjedi, A. | Nazer, A. | +9

10

Retraction Note: Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression

enthalten in: Pharmaceutical research | 2022

von Izadi, S. | Moslehi, A. | Kheiry, H. | +14